SSKN logo

STRATA Skin Sciences (SSKN) Company Overview

Profile

Full Name:

STRATA Skin Sciences, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

November 3, 2005

Indexes:

Not included

Website:

http://www.strataskinsciences.com

Description:

SSKN, or STRATA Skin Sciences, is a medical technology company focused on developing innovative solutions for skin conditions. They provide advanced treatments and devices for dermatology, aiming to improve patient outcomes and enhance the quality of care in skin health.

Key Details

Price

$2.64

Market Cap

$11.01 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$33.36 M(-7.75% YoY)

Annual EPS

-$3.10(-93.75% YoY)

PE Ratio

-

Annual ROE

-62.75%

Annual Debt To Equity

1.19

Beta

0.21

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 7, 2024

Analyst ratings

Recent major analysts updates

May 16, 23 CG Capital
Outperform
Nov 3, 20 HC Wainwright & Co.
Buy
Mar 17, 20 HC Wainwright & Co.
Neutral
Dec 9, 19 Ladenburg Thalmann
Buy
Nov 21, 19 Oppenheimer
Outperform
Dec 10, 18 Northland Securities
Outperform
Dec 10, 18 Northland Capital Markets
Outperform

Screeners with SSKN included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.64
SSKN price is $2.64

Price All-time High

$5835.00
SSKN price is currently -99.95% below its historical high of $5835.00

Price Analysts Target

$16.00
SSKN price is currently -83.50% lower than the consensus analysts' forecast

Price Most Recent Change

-1.49%
SSKN price was down -1.49% on Feb 27, 2025

Price YTD Change

-9.28%
SSKN price is down -9.28% since January 1st

Price 3-Year Change

-83.8%
SSKN price is down -83.8% over the past 3 years

Market cap

Market Cap

$11.01 M
SSKN market capitalization is $11.01 million

Market Cap 3-Year Change

-80.54%
SSKN market capitalization is down -80.54% over the past 3 years

Market Cap All-time High

$260.82 M
SSKN market capitalization is currently -95.78% below its historical high of $260.82 million

Market Cap Sector Rank

18.82%
SSKN market capitalization is higher than 18.82% of companies in Healthcare sector

Technical

Beta

0.21
SSKN beta is 0.21

200-day SMA

$3.09
SSKN price is currently -14.54% below its 200-day simple moving average

14-day RSI

41.74
SSKN 14-day relative strength index is 41.74

30-day Relative Volume

0.74
SSKN 30-day relative volume is 0.74

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$33.36 M
SSKN annual revenue is $33.36 million

Annual Revenue Analysts Estimate

$33.01 M
SSKN annual revenue is currently +1.05% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-7.75%
SSKN annual revenue is down -7.75% year-on-year

Annual Revenue Sector Rank

42.08%
SSKN annual revenue is higher than 42.08% of companies in Healthcare sector

Profit

Annual Gross Profit

$18.46 M
SSKN annual gross profit is $18.46 million

Annual Gross Margin

55.34%
SSKN annual gross profit margin is 55.34%

Annual Operating Profit

-$6.32 M
SSKN annual operating income is -$6.32 million

Annual Operating Margin

-18.95%
SSKN annual operating profit margin is -18.95%

Annual Net Income

-$10.83 M
SSKN annual net profit is -$10.83 million

Annual Net Margin

-32.47%
SSKN annual net profit margin is -32.47%

EPS

Annual EPS

-$3.10
SSKN annual earnings per share is -$3.10

Annual EPS Analysts Estimate

-$1.05
SSKN annual earnings per share is currently +195.24% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-93.75%
SSKN annual earnings per share is down -93.75% year-on-year

Annual EPS Sector Rank

31.69%
SSKN annual earnings per share is higher than 31.69% of companies in Healthcare sector

ROA & ROE

Annual ROA

-22.97%
SSKN annual return on assets is -22.97%

Annual ROE

-62.75%
SSKN annual return on equity is -62.75%

EBIT & EBITDA

Annual EBIT

-$9.28 M
SSKN annual earnings before interest & taxes is -$9.28 million

Annual EBITDA

-$3.38 M
SSKN annual EBITDA is -$3.38 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SSKN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SSKN price to earnings ratio is unknown

PB Ratio

PB Ratio

1.18
SSKN price to book ratio is 1.18

PB Ratio Sector Rank

47.02%
SSKN price to book ratio is higher than 47.02% of companies in Healthcare sector

PS Ratio

PS Ratio

0.34
SSKN price to sales ratio is 0.34

PS Ratio Sector Rank

9.88%
SSKN price to sales ratio is higher than 9.88% of companies in Healthcare sector

Enterprise value

Enterprise Value

$20.43 M
SSKN enterprise value is $20.43 million

Enterprise Value Sector Rank

29.06%
SSKN enterprise value is higher than 29.06% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.26
SSKN EV/EBITDA is -10.26

EV/EBITDA Sector Rank

12.64%
SSKN EV/EBITDA is higher than 12.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.28
SSKN annual current ratio is 1.28

Annual Quick Ratio

1.06
SSKN annual quick ratio is 1.06

Leverage

Annual Debt To Equity

1.19
SSKN annual debt to equity ratio is 1.19

Annual Interest Coverage Ratio

-5.66
SSKN annual interest coverage ratio is -5.66

Risk & Stability

Piotroski F-Score

4
SSKN piotroski f-score is 4

Altman Z-Score

-7.55
SSKN altman z-score is -7.55

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$42.02 M
SSKN annual total assets is $42.02 million

Annual Non Current Assets

$26.47 M
SSKN annual long term assets is $26.47 million

Annual Current Assets

$15.54 M
SSKN annual total current assets is $15.54 million

Annual Cash & Cash Equivalents

$6.78 M
SSKN annual cash & cash equivalents is $6.78 million

Equity

Annual Book Value

$12.69 M
SSKN annual book value is $12.69 million

Annual Working Capital

$3.37 M
SSKN annual working capital is $3.37 million

Liabilities

Annual Total Liabilities

$29.33 M
SSKN annual total liabilities is $29.33 million

Annual Total Long Term Liabilities

$17.15 M
SSKN annual total long term liabilities is $17.15 million

Annual Current Liabilities

$12.17 M
SSKN annual total current liabilities is $12.17 million

Annual Accounts Payable

$3.34 M
SSKN annual accounts payable is $3.34 million

Debt

Annual Total Debt

$15.63 M
SSKN annual total debt is $15.63 million

Annual Total Debt 1-Year Change

+85.2%
SSKN annual total debt is up +85.2% year-on-year

Annual Long Term Debt

$15.28 M
SSKN annual long term debt is $15.28 million

Annual Short Term Debt

$352.00 K
SSKN annual short term debt is $352.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$39.68 M
SSKN annual total expenses is $39.68 million

Annual Operating Expenses

$24.78 M
SSKN annual total operating expenses is $24.78 million

Annual Cost Of Goods Sold

$14.90 M
SSKN annual cost of goods sold is $14.90 million

Annual SGA

$23.46 M
SSKN annual SGA is $23.46 million

Annual D&A

$5.90 M
SSKN annual depreciation & amortization is $5.90 million

Annual Interest Expense

$1.64 M
SSKN annual interest expense is $1.64 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$519.00 K
SSKN annual cash flow from operations is -$519.00 thousand

Annual CFO 1-Year Change

+43.83%
SSKN annual cash flow from operations is up +43.83% year-on-year

Annual CFI

-$5.02 M
SSKN annual cash flow from investing activities is -$5.02 million

Annual CFI 1-Year Change

-14.93%
SSKN annual cash flow from investing activities is down -14.93% year-on-year

Annual CFF

$6.86 M
SSKN annual cash flow from financing activities is $6.86 million

Annual CFF 1-Year Change

+1472.2%
SSKN annual cash flow from financing activities is up +1472.2% year-on-year

Free CashFlow

Annual FCF

-$5.54 M
SSKN annual free cash flow is -$5.54 million

Annual FCF 1-Year Change

-18.84%
SSKN annual free cash flow is down -18.84% year-on-year

CAPEX

Annual CAPEX

$5.02 M
SSKN annual capital expenditures is $5.02 million

Annual CAPEX 1-Year Change

+34.34%
SSKN annual capital expenditures is up +34.34% year-on-year

Institutional Ownership

Similar stocks

ONVO logo
Organovo Holdings (ONVO)
CANF logo
Can-Fite BioPharma (CANF)
BRTX logo
BioRestorative Therapies (BRTX)
MDNA logo
Medicenna Therapeutics (MDNA)
IMRN logo
Immuron Limited (IMRN)
MGRX logo
Mangoceuticals (MGRX)
SNSE logo
Sensei Biotherapeutics (SNSE)
Kindly MD (KDLY)
PRPO logo
Precipio (PRPO)

FAQ

  • What is the ticker symbol for STRATA Skin Sciences?
  • Does STRATA Skin Sciences pay dividends?
  • What sector is STRATA Skin Sciences in?
  • What industry is STRATA Skin Sciences in?
  • What country is STRATA Skin Sciences based in?
  • When did STRATA Skin Sciences go public?
  • Is STRATA Skin Sciences in the S&P 500?
  • Is STRATA Skin Sciences in the NASDAQ 100?
  • Is STRATA Skin Sciences in the Dow Jones?
  • When was STRATA Skin Sciences's last earnings report?
  • When does STRATA Skin Sciences report earnings?
  • Should I buy STRATA Skin Sciences stock now?

What is the ticker symbol for STRATA Skin Sciences?

The ticker symbol for STRATA Skin Sciences is NASDAQ:SSKN

Does STRATA Skin Sciences pay dividends?

No, STRATA Skin Sciences does not pay dividends

What sector is STRATA Skin Sciences in?

STRATA Skin Sciences is in the Healthcare sector

What industry is STRATA Skin Sciences in?

STRATA Skin Sciences is in the Medical Devices industry

What country is STRATA Skin Sciences based in?

STRATA Skin Sciences is headquartered in United States

When did STRATA Skin Sciences go public?

STRATA Skin Sciences's initial public offering (IPO) was on November 3, 2005

Is STRATA Skin Sciences in the S&P 500?

No, STRATA Skin Sciences is not included in the S&P 500 index

Is STRATA Skin Sciences in the NASDAQ 100?

No, STRATA Skin Sciences is not included in the NASDAQ 100 index

Is STRATA Skin Sciences in the Dow Jones?

No, STRATA Skin Sciences is not included in the Dow Jones index

When was STRATA Skin Sciences's last earnings report?

STRATA Skin Sciences's most recent earnings report was on Nov 13, 2024

When does STRATA Skin Sciences report earnings?

The next expected earnings date for STRATA Skin Sciences is Mar 27, 2025

Should I buy STRATA Skin Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions